USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its fiscal third quarter ended September 28, 2019.
Third quarter 2019 net sales were $260.6 million, compared with $296.8 million in the prior-year period, or a 12.2 percent decrease year-over-year. The company’s total number of active Customers at the end of the third quarter was 558,000, compared to 615,000 in the prior-year period.
“Although we continue to face a challenging sales environment in China and other regions, we were pleased to see sales in several markets improve on a consecutive quarter basis,” said Kevin Guest, chief executive officer.
Net sales in the Asia Pacific region decreased by 12.9 percent to $208.6 million for the third quarter of 2019. On a constant currency-basis, net sales in the Asia Pacific region decreased 10.7 percent during the third quarter of 2019. The total number of active Customers in the Asia Pacific region decreased by 10.1 percent year-over-year. Within Asia Pacific, net sales:
- Decreased 18.6% in Greater China (down 16.4% on a constant currency basis);
- Decreased 7.6% in Southeast Asia Pacific (down 6.8% on a constant currency basis); and
- Increased 17.1% in North Asia (up 24.3% on a constant currency basis).
Active Customers decreased by 17.3 percent in Greater China and by 2.6 percent in Southeast Asia Pacific. In North Asia, Active customers increased by 28.2 percent
Net sales in the Americas and Europe region decreased by 9 percent to $52.0 million for the third quarter of 2019, primarily due to a 6.1 percent decrease in active Customers.
